CBP501

· CanBas Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CBP501, covering 2017-03-14 to 2021-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [Phase 1, Phase 2]